6OVA Stock Chart & Stats
€4.86
€0.18(4.46%)
At close: 4:00 PM EDT
€4.86
€0.18(4.46%)
Day’s Range― - ―
52-Week Range€4.00 - €7.15
Previous CloseN/A
Volume0.00
Average Volume (3M)33.00
Market Cap
€295.17M
Enterprise Value€326.26
Total Cash (Recent Filing)€136.51M
Total Debt (Recent Filing)€2.86M
Price to Earnings (P/E)64.6
Beta0.68
Next Earnings
Nov 05, 2026EPS Estimate
0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.12
Shares Outstanding63,414,160
10 Day Avg. Volume53
30 Day Avg. Volume33
Financial Highlights & Ratios
PEG Ratio1.48
Price to Book (P/B)2.08
Price to Sales (P/S)5.09
P/FCF Ratio70.19
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€8.19Price Target Upside68.58% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
EPS Forecast (FY)0.12
Revenue Forecast (FY)€81.34M
Bulls Say, Bears Say
Bulls Say
Recurring Revenue And ARR GrowthThe high recurring-revenue mix improves visibility and customer retention economics, while low-double-digit organic ARR growth indicates continued demand for Vitalhub’s healthcare workflow and care-management software.
Strong Balance Sheet And M&A CapacityMinimal leverage and substantial liquidity reduce financial risk and give Vitalhub flexibility to fund product investment, pursue complementary acquisitions, and withstand variability in healthcare procurement cycles.
Improving Profitability And Integration BenefitsImproving EBITDA alongside completed integration work suggests that scale and acquisition synergies can support operating leverage. Strong gross margins and ongoing AI development may further expand software earnings power over time.
Bears Say
UK Contract And Regulatory UncertaintyThe NHS procurement outcome and related break clause could affect customer commitments, sales cycles, and ARR in the UK. This creates a durable execution risk because public-sector contract decisions can materially shape regional growth.
Moderating Growth And Modest ReturnsAlthough Vitalhub remains profitable, slower reported growth and modest returns on equity indicate that the business is not yet converting its platform and balance-sheet advantages into consistently high shareholder returns.
Cash-Flow VolatilityRecent cash generation is encouraging, but the historical variability shows that implementation timing, working capital, and acquisition activity can disrupt conversion of accounting earnings into dependable free cash flow.
Vitalhub News
6OVA FAQ
What was Vitalhub’s price range in the past 12 months?
Vitalhub lowest stock price was €4.00 and its highest was €7.15 in the past 12 months.
What is Vitalhub’s market cap?
Vitalhub’s market cap is €295.17M.
When is Vitalhub’s upcoming earnings report date?
Vitalhub’s upcoming earnings report date is Nov 05, 2026 which is in 51 days.
How were Vitalhub’s earnings last quarter?
Vitalhub released its earnings results on Aug 06, 2026. The company reported €0.019 earnings per share for the quarter, missing the consensus estimate of €0.044 by -€0.025.
Is Vitalhub overvalued?
According to Wall Street analysts Vitalhub’s price is currently Undervalued.
Does Vitalhub pay dividends?
Vitalhub does not currently pay dividends.
What is Vitalhub’s EPS estimate?
Vitalhub’s EPS estimate is 0.04.
How many shares outstanding does Vitalhub have?
Vitalhub has 63,414,160 shares outstanding.
What happened to Vitalhub’s price movement after its last earnings report?
Vitalhub reported an EPS of €0.019 in its last earnings report, missing expectations of €0.044. Following the earnings report the stock price went down -0.461%.
Which hedge fund is a major shareholder of Vitalhub?
Currently, no hedge funds are holding shares in DE:6OVA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Vitalhub Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€8.19 (68.58% Upside)
€8.19 (68.58% Upside)
Blogger Sentiment
Bullish
DE:6OVA Sentiment 100%
Sector Average 62%
Sector Average 62%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-30.92%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
37.72%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Vitalhub
Vitalhub Corp., through its subsidiaries, provides innovative technological solutions to health and human service providers internationally, specifically catering to markets in Canada, the United States, the United Kingdom, Australia, and Western Asia. The company's diverse array of offerings comprises electronic healthcare records, case management systems, care coordination platforms, tools for optimizing patient flow and operational insights, and various mobile applications. Incorporated in 2010, Vitalhub is headquartered in Toronto, Canada.
6OVA Stock 12 Month Forecast
Average Price Target
€8.19
▲(68.58% Upside)
Technical Analysis
Diagnos
―
―
nDatalyze Corp
―
Comprehensive Healthcare Systems Inc
―
UniDoc Health Corp
―